agalsidase beta

Trials studying agalsidase beta

• phase3A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Diseaseactive not recruitingn=104
• phase3Switch Over Study of Biosimilar Agalsidase Beta for Fabry Diseasecompletedn=20
• phase4A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazymecompletedn=8
• phase1PK/PD Study of 2 Agalsidase Formulations in Single Dose of 1 mg/kg Administered to Healthy Volunteers as IV Infusioncompletedn=24
• phase4China Post-marketing Surveillance (PMS) Study of Fabrazyme®completedn=22
• phase3Evaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry Diseaserecruitingn=24
• phase4Study of the Effects of Fabrazyme Treatment on Lactation and Infantsterminatedn=7
• phase3Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Functioncompletedn=78